Article
B-Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
13 Oct 2022
Abstract excerpt
BACKGROUND AND OBJECTIVES: Autologous hematopoietic stem cell transplantation (aHSCT) is increasingly used to treat aggressive forms of multiple sclerosis (MS). This procedure is believed to result in an immune reset and restoration of a self-tolerant immune system. Immune reconstitution has been extensively studied for T cells, but only to a limited extent for B cells. As increasing evidence suggests an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
